CDKN1A and neoplasm: One stable tumor (MEL101) was sufficiently large that it provided a unique opportunity to study tumor mass dormancy in detail in a human patient rather than a mouse model.(33) Deep characterization of this tumor identified that the proportion of p27+ and/or p21+ QCCs in these tumors was similar to, or lower than the proportion of proliferating cells.